A regional centralized microbiology service in Calgary for the rapid diagnosis of malaria

Archives of Pathology and Laboratory Medicine

Volumn 127, Issue 6, 2003, Pages 687-693

  Church, Deirdre L ^a,b,c   Lichtenfeld, Angelika ^a   Elsayed, Sameer ^a,c   Kuhn, Susan ^c   Gregson, Daniel B ^a,b,c  

^a CALGARY LABORATORY SERVICES   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BLOOD SMEAR; CANADA; CENTRALIZATION; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; HUMAN TISSUE; LABORATORY; MAJOR CLINICAL STUDY; MALARIA; MALE; MICROBIOLOGICAL EXAMINATION; PERFORMANCE; PLASMODIUM; POLYMERASE CHAIN REACTION; URBAN AREA;

ALBERTA; ANIMALS; BLOOD SPECIMEN COLLECTION; CENTRALIZED HOSPITAL SERVICES; COMPETENCY-BASED EDUCATION; HOSPITAL PLANNING; HUMANS; LABORATORIES, HOSPITAL; MALARIA, FALCIPARUM; MALARIA, VIVAX; MICROBIOLOGICAL TECHNIQUES; PATHOLOGY, CLINICAL; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; QUALITY ASSURANCE, HEALTH CARE; SPECIMEN HANDLING; URBAN HEALTH SERVICES;

EID: 0038580801     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Committee to Advise on Tropical Medicine and Travel (CATMAT), Laboratory for Disease Control. Canadian recommendations for the prevention and treatment of malaria among international travelers. Can Commun Dis Rep. 2000;26(suppl 2):1-42.
2. World Health Organization Expert Committee on Malaria. Twentieth Report. Geneva, Switzerland: World Health Organization; 2000:1-71.
3. Centers for Disease Control and Prevention. Summary of notifiable diseases-United States. MMWR Morb Mortal Wkly Rep. 2000;49:1-128.
4. Humar A, Sharma S, Zoutman D, Kain KC. Fatal falciparum malaria in Canadian travelers. Can Med Assoc J. 1997;156:1165-1167.
5. Kain KC, Harrington MA, Tennyson S, Keystone JS. Imported malaria: prospective analysis of problems in diagnosis and management. Clin Infect Dis. 1998;27:142-149.
6. Murphy GS, Basri H, Purnomo, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet. 1993;341:96-100.
7. Kain KC. Chemotherapy for drug-resistant malaria. Can J Infect Dis. 1996; 7:25-33.
8. Church DL, Hall P. Centralization of a regional clinical microbiology service: the Calgary experience. Can J Infect Dis. 1999;10:393-402.
9. Garcia LS. Malaria and babesiosis. In: Diagnostic Medical Parasitology. 4th ed. Washington, DC: American Society for Microbiology Press; 2001:159-204.
10. Ontario Medical Association. Laboratory proficiency testing program: recommendations for examination of blood films for malaria parasites. Toronto, Ontario: Ontario Medical Association; 1996;3:36-39.
11. Anthony RL, Bangs MJ, Anthony JM, Purnomo. On-site diagnosis of Plasmodium falciparum, P. vivax and P. malariae by using the Quantitative Buffy Coat system. J Parasitol. 1992;78:994-998.
12. Brown AE, Kain KC, Pipithkul J, Webster HK. Demonstration by the polymerase chain reaction of mixed Plasmodium falciparum and P. vivax infection undetected by conventional microscopy. Trans R Soc Trop Med Hyg. 1992;86: 609-612.
13. Sethabutr O, Brown AE, Panyim S, Kain KC, Webster HK, Echeverria P. Detection of Plasmodium falciparum by polymerase chain reaction in a field study. J Infect Dis. 1992;166:145-148.
14. Svenson JE, MacLean JD, Gyorkos TW, Keystone J. Imported malaria: clinical presentation and examination of symptomatic travelers. Arch Intern Med. 1995;155:861-868.
15. Milne LM, Kyi MS, Chiodini PL. Accuracy of routine laboratory diagnosis of malaria in the United Kingdom. J Clin Pathol. 1994;47:740-742.